An interventional study of Video Laryngoscopy and Direct Laryngoscopy in Respiratory Distress Syndrome (Neonatal) and Surfactant Deficiency Syndrome Neonatal, sponsored by University of Texas Southwestern Medical Center. Recruiting at 1 site in United States. Open to participants aged 0 Hours to 3 Days. Per ClinicalTrials.gov, last updated 2026-06-15.
Sponsored by University of Texas Southwestern Medical Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 43 studies in Pulmonary Atelectasis with a site in United States — 11 open to participants now, 11 under way, 1 of them phase 3. Pulmonary Atelectasis · United States.
Among the 43 studies in Pulmonary Atelectasis with a site in United States, this one is the 12th largest by planned enrollment of the 37 interventional ones that give a count, is one of 4 that started in 2026, is one of 31 with no phase, reaches primary completion later than 6 of the 10 other live ones, and was the 42nd registered.
378 studies on the registry are indexed under Pulmonary Atelectasis; 91 are open to participants now.
Browse Pulmonary Atelectasis studies →11 of the 43 studies in Pulmonary Atelectasis with a site in United States are open now. Recruiting first, the newest first:
University of Texas Southwestern Medical Center · Sites in United States
Ages 0 hrs–72 hrs
University of Arkansas · Sites in United States
Hackensack Meridian Health · Sites in United States
Ages 34 wk–36 wk
ONY · Sites in United States
Ages 29 wk–36 wk
NYU Langone Health · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 51 Pulmonary Atelectasis studies recruiting now, 20 (39%) set no upper age limit and 23 (45%) stop at 75 or younger; 24 take children under 18; 2 take healthy volunteers.
This study: 0 Hours to 3 Days · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
43 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 3 · Phase 3 2 · Phase 4 1
First in 2005; this study’s year is marked. 4 started in 2026.
This study's planned enrollment of 100 is above the median of 60 across 268 interventional studies indexed under Pulmonary Atelectasis.
Median enrollment 40 across the 37 interventional studies, 300 across the 5 observational. Of the 26 that completed or were terminated, 13 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 43 have an industry lead sponsor. The 10 most frequent:
University of Texas Southwestern Medical Center is the lead sponsor of 1,012 studies on the registry; 200 are open to participants now.
Of its 139 completed or terminated interventional studies of FDA-regulated products, 105 (76%) have results posted.
University of Texas Southwestern Medical Center has 3 studies filed under Pulmonary Atelectasis — fewer than ten, so there is no comparison to draw.
5 of the studies in Pulmonary Atelectasis with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06538376Brigham and Women's HospitalClinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU | 2026-11 |
| NCT07674953University of ArkansasHow Different Levels of CPAP Affect Oxygen Delivery and Lung Expansion in Preterm Infants | 2026-12 |
| NCT05675345NYU Langone HealthPhysiological Effects of Continuous Negative External Pressure for Acute Hypoxemic Respiratory Failure | 2027-06-30 |
| NCT07418502University of Texas at AustinPressure Targeting During High Flow Therapy in Premature Infants | 2027-08 |
| NCT07216053Hackensack Meridian HealthPredictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates | 2027-11 |
Add all 5 to your calendar (.ics) → With an account.
Among the 43 studies in Pulmonary Atelectasis with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Many preterm babies born between 22-28+6 weeks' estimated gestational age (EGA) need surfactant, a medicine that helps the lungs. The goal of the study is to compare the use of video-based visualization to direct visualization during a procedure called less invasive surfactant administration (LISA). The main questions the study aims to answer are: 1) does one method of visualization have a increased rate of giving the medicine successfully on the first attempt? 2) what benefits are there of each method?
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A video laryngoscopy will be used to visualize the vocal cords and place the LISA catheter for surfactant administration
Procedure: Video Laryngoscopy
Direct laryngoscopy (no camera) will be used to visualize the vocal cords and place the LISA catheter for surfactant administration
Procedure: Direct Laryngoscopy
Video Laryngoscopy will be used to visualize the vocal cords and place the LISA catheter
Direct Laryngoscopy will be used to visualize the vocal cords and place the LISA catheter
Rate of first attempt success
Time frame: During procedure
Duration of desaturation below 80% SpO2 (sec),
Time frame: during procedure
Duration of bradycardia (HR <100 bpm)
Time frame: procedure duration
Number of desaturation/bradycardia episodes
Time frame: during procedure
Number of surfactant installation attempts
Time frame: during procedure
Time to completion of surfactant installation
Time frame: during procedure
Time to insertion of thin catheter
Time frame: during procedure
Amount of surfactant in stomach at the end of the procedure
Time frame: within 5 min after procedure
Mean maximum fractioned inspired O2 used
Time frame: during procedure
Lowest oxygen saturation during catheter insertion
Time frame: during procedure
Fractionated inspired oxygen (FiO2) at 60 mins post procedure
Time frame: 60 minutes post-procedure
Lowest heart rate during catheter insertion
Time frame: during procedure
Cross over to alternative method
Time frame: during procedure
Incidence of intubation at 72 hours post surfactant administration
Time frame: procedure to 72 hours post-procedure
Incidence of pneumothorax
Time frame: procedure to 72 hours post-procedure
Incidence of severe (grade III/IV) intraventricular hemorrhage
Time frame: Birth to discharge
Continuous Positive Expiratory Pressure (CPAP) at 60 mins post procedure
Time frame: 60 minutes post-procedure
Intubation during procedure
Time frame: During Procedure
Change in provider during procedure
Time frame: during procedure
Survival to discharge or 90 days
Time frame: up to 90 days
Plan to share: Undecided
Started Jun 2026 (actual). Primary completion is estimated for Jun 2028, 24 months after the start.
Of 155 non-industry interventional studies with no phase under Pulmonary Atelectasis, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 24 months is above that.
Counting every sponsor, half of 157 studies reached it within 11 months; a quarter within 5 and three quarters within 21.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Texas Southwestern Medical Center →